From Diabetes Drugs to Investment Megatrend: When Will GLP-1 Drugs Transform Our World?
Will GLP-1s put an end to obesity and truly change the world as we know it, including the longer-term investment landscape? Equity Analysts Gaby Greenman and Rob Shea share their thoughts.
Read Article